Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MACROGENICS INC Director's Dealing 2026

Feb 10, 2026

34129_dirs_2026-02-10_5e551038-0d3f-476d-af90-2be7f07bafc1.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2026-02-08

Reporting Person: Koenig Scott (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2026-02-08 Common Stock M 15831 Acquired 846075 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2026-02-08 Restricted Stock Unit $ M 15831 Disposed Common Stock (15831) Direct

Footnotes

F1: Restricted stock units convert into the Company's stock on a one-for-one basis.

F2: On February 8, 2024, the reporting person was granted 95,000 restricted stock units. One-third of the restricted stock units vested after one year and one-half of the remaining units vested pursuant to the reporting person's "Separation Agreement" on August 13, 2025. The remaining units vest in two equal installments on the anniversary of the grant date.